- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Sep 15, 2016
Targets & Mechanisms
KOR-recting MS
Why the MS field might invest in biased opioid agonists
BioCentury | Sep 1, 2016
Targets & Mechanisms
Biased against pain
How Epiodyne aims to make opioids safer
Items per page:
1 - 2 of 2